× |
|
Implementation of the Texas Medication Algorithm Project Patient and Family Education Program PDF |
$40.00 |
|
$40.00 |
× |
|
A Randomized, Placebo-Controlled, Dose-Response Trial of Venlafaxine Hydrochloride in the Treatment of Major Depression PDF |
$40.00 |
|
$40.00 |
× |
|
Antipsychotic Polypharmacy, Part 2: Why Use 2 Antipsychotics When 1 Is Not Good Enough? PDF |
$40.00 |
|
$40.00 |
× |
|
Age at the Time of Exposure to Trauma Modulates the Psychopathological Profile in Patients With Early Psychosis PDF |
$40.00 |
|
$40.00 |
× |
|
Mental Illness and Psychotropic Drug Use Among Prescription Drug Overdose Deaths: A Medical Examiner Chart Review PDF |
$40.00 |
|
$40.00 |
× |
|
Droperidol: Efficacy and Side Effects in Psychiatric Emergencies PDF |
$40.00 |
|
$40.00 |
× |
|
Clozapine Treatment for Neuroleptic-Induced Tardive Dyskinesia, Parkinsonism, and Chronic Akathisia in Schizophrenic Patients PDF |
$40.00 |
|
$40.00 |
× |
|
Bullying Victimization Among Children With Mental, Emotional, Developmental, or Behavioral Problems: A US Population-Based Study PDF |
$40.00 |
|
$40.00 |
× |
|
Predicting Initial Specialist Mental Health Care Use in Adolescence Using Self-, Parent-, and Teacher-Reported Problem Behavior: A Prospective Community-Based Record-Linkage Study PDF |
$40.00 |
|
$40.00 |
× |
|
Opiate Antagonists Do Not Interfere With the Clinical Benefits of Stimulants in ADHD: A Double-Blind, Placebo-Controlled Trial of the Mixed Opioid Receptor Antagonist Naltrexone PDF |
$40.00 |
|
$40.00 |
× |
|
Efficacy and Safety of Duloxetine 60 mg Once Daily in the Treatment of Pain in Patients With Major Depressive Disorder and At Least Moderate Pain of Unknown Etiology: A Randomized Controlled Trial PDF |
$40.00 |
|
$40.00 |
× |
|
Impulse-Control Disorders in Adolescent Psychiatric Inpatients: Co-Occurring Disorders and Sex Differences PDF |
$40.00 |
|
$40.00 |
× |
|
Manic Switch in a Patient With Depression in the Setting of COVID-19 Treatment PDF |
$40.00 |
|
$40.00 |
|